Albemarle Corp buy Jefferies Financial Group Inc.
Start price
28.01.26
/
50%
€154.46
Target price
28.01.27
€191.80
Performance (%)
-2.42%
Price
19:20
€150.72
Summary
This prediction is currently active. With a performance of -2.42%, the BUY prediction by Jefferies_Financial_ is trending in the wrong direction. This prediction currently runs until 28.01.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Albemarle Corp | -2.42% |
| iShares Core DAX® | 0.170% |
| iShares Nasdaq 100 | 0.515% |
| iShares Nikkei 225® | 1.614% |
| iShares S&P 500 | -0.719% |
Comments by Jefferies_Financial_ for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its price target raised by analysts at Jefferies Financial Group Inc. from $210.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat